1. Home
  2. MPB vs SLS Comparison

MPB vs SLS Comparison

Compare MPB & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid Penn Bancorp

MPB

Mid Penn Bancorp

HOLD

Current Price

$34.64

Market Cap

827.5M

Sector

Finance

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$12.39

Market Cap

924.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPB
SLS
Founded
1868
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.5M
924.5M
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
MPB
SLS
Price
$34.64
$12.39
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$37.00
$10.00
AVG Volume (30 Days)
127.9K
7.9M
Earning Date
04-21-2026
05-11-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
50.00
EPS
0.36
N/A
Revenue
N/A
N/A
Revenue This Year
$30.95
N/A
Revenue Next Year
$9.45
$110.98
P/E Ratio
$94.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.50
$1.39
52 Week High
$35.22
$11.06

Technical Indicators

Market Signals
Indicator
MPB
SLS
Relative Strength Index (RSI) 56.49 77.80
Support Level $32.81 $3.72
Resistance Level $34.82 N/A
Average True Range (ATR) 0.69 0.80
MACD 0.07 0.29
Stochastic Oscillator 71.99 96.23

Price Performance

Historical Comparison
MPB
SLS

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: